FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly
FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly
MedShadow ArticlesMedical Journals Have Flaws, But Government Oversight Isn’t the FixSuzanne B. Robotti
MedShadow ArticlesWhat Is Addyi? The Controversy Behind the Drug Nicknamed the ‘Female Viagra’Emma Yasinski and Sami Roberts
MedShadow ArticlesFDA SIDE EFFECTS UPDATE: Tetracycline Antibiotics and Serious Skin Reactions, New Rinvoq Warnings for GCAKatie Rowley
MedShadow ArticlesIs Benzoyl Peroxide Still Safe? What to Know About Acne Treatment RecallsRona Cherry
MedShadow ArticlesRethinking Statins: Inside the Fierce Debate Over Cholesterol and Heart HealthKristel Tjandra and Gillian Dohrn
MedShadow ArticlesThe PPI Debate: Are Heartburn Drugs Like Prilosec and Nexium Linked to Dementia?Carrie Arnold, MA, MPH
MedShadow ArticlesMission Critical Update: Medication Safety Updates from the FDA DelayedEmma Yasinski
MedShadow ArticlesFDA SIDE EFFECTS UPDATE: Gadolinium Contrast Agents (GBCAs) and Lung ProblemsKatie Rowley
